Eloxx Pharma Chairman Tomer Kariv resigns from board effective Dec 27

Eloxx Pharmaceuticals, Inc.

Tomer Kariv resigned as Director, Chairman of the Board, and committee member effective December 27, 2023.
Resignation is not due to any disagreement with the Company's operations, policies, or practices.
Company's common stock currently quoted on OTC Pink following Nasdaq delisting appeal.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Tomer Kariv

Chairman of the Board

ELOX · Eloxx Pharmaceuticals, Inc.

Effective: 2023-12-27
Filed: December 28, 2023, 6:59 PM ET

Mr. Tomer Kariv notified the Board of Directors (the “Board”) of Eloxx Pharmaceuticals, Inc. (the “Company”) of his resignation from the Board and his position as Chairman of the Board and from the committee of the Board on which he serves.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Tomer Kariv resigned as Chairman of the Board at Eloxx Pharmaceuticals, Inc..

Action: resigned
Role: Chairman of the Board

Exact text from the filing

Mr. Tomer Kariv notified the Board of Directors (the “Board”) of Eloxx Pharmaceuticals, Inc. (the “Company”) of his resignation from the Board and his position as Chairman of the Board and from the committee of the Board on which he serves.

View on SEC.gov

Eloxx Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-130052

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.